Thompson C , Perry C , Gaylor D, Tachovsky A, Burkhalter B, Haws L . 2011. Derivation of an oral reference dose and drinking water screening level for sulfolane using benchmark dose modeling. Presented at the Society of Toxicology’s 50th Annual Meeting, March 6-10, Washington, D.C.
View Abstract
Publication: Abstracts and Presentations
Thompson CM, Proctor DM, Haws LC, Hebert CD, Grimes SD, Shertzer HG, Kopec AK, Hixon JG, Zacharewski TR, Harris MA . 2011. Investigation of the mode of action underlying the tumorigenic response induced in B6C3F1 mice exposed orally to hexavalent chromium. Toxicol Sci 123(1): 58-70.
View Abstract
Publication: Manuscripts
/ Topics: Cr(VI) MOA Study Manuscripts , Hexavalent Chromium
Mounho B. 2011. Definitions and standards for the approval of biosimilar products. Presented at American College of Toxicology Annual Meeting, November, Phoenix, AZ.
Publication: Abstracts and Presentations
Bogen KT, Brorby GP , Berman DW, Sheehan PJ, Floyd M. 2011. Measuring mixed cellulose ester (MCE) filter mass under variable humidity conditions. Ann Occup Hyg 55(5)485-494.
View Abstract
Publication: Manuscripts
Urban J , Fitzgerald L, Burkhalter B, Staskal D, Harris M , Haws L . 2011. BTEX serum levels in the general U.S. population: An analysis of 2003-2004 NHANES dataset. Presented at the Society of Toxicology’s 50th Annual Meeting, March 6-10, Washington, D.C.
View Abstract
Publication: Abstracts and Presentations
Thompson CM, Haws LC, Harris MA , Gatto NM, Proctor DM . 2011. Application of the U.S. EPA mode of action framework for purposes of guiding future research: A case study involving the oral carcinogenicity of hexavalent chromium. Toxicol Sci 119(1):20-40.
View Abstract
Publication: Manuscripts
/ Topics: Cr(VI) MOA Study Manuscripts , Hexavalent Chromium
Diliberto JJ, Sirinek L, Burkhalter B, Wikoff DS , Hixon G , Becker J, Patterson DG, Turner W, Tachovsky JA, Birnbaum LS, Haws LC. 2011. Endometriosis in a cohort of women living in the Kanawha River Valley in West Virginia: Blood levels of non-dioxin-like PCBs and relationship with BMI and age. Presented at Dioxin 2011, August 21-25, Brussels, Belgium.
Publication: Abstracts and Presentations
Bussiere J, Leach M, Price K, Mounho B , Lightfoot-Dunn R. 2011. Survey results on the use of the tissue cross-reactivity immunohistochemistry assay. Reg Toxicol Pharm 59(3):493-505.
View Abstract
Publication: Manuscripts
Oller A, Henderson RG. 2011. Bioaccessibility testing and its application to read-across for hazard assessment and risk characterisation of metals. Annual meeting of the Belgian Society for Toxicology and Ecotoxicology (BelTox).
Publication: Abstracts and Presentations
Haws LC , DeVito MJ, Walker NJ, Harris MA , Tachovsky JA, Birnbaum LS, Farland WH, Wikoff DS . 2011. Development of a consensus-based weighting framework for evaluating estimates of relative potency for dioxin-like compounds that includes consideration of data from human cells. Presented at Dioxin 2011, August 21-25, Brussels, Belgium.